333 related articles for article (PubMed ID: 23549584)
1. Melatonin secretion and the incidence of type 2 diabetes.
McMullan CJ; Schernhammer ES; Rimm EB; Hu FB; Forman JP
JAMA; 2013 Apr; 309(13):1388-96. PubMed ID: 23549584
[TBL] [Abstract][Full Text] [Related]
2. A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
McMullan CJ; Rimm EB; Schernhammer ES; Forman JP
Heart; 2017 May; 103(9):694-701. PubMed ID: 27806988
[TBL] [Abstract][Full Text] [Related]
3. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
[TBL] [Abstract][Full Text] [Related]
4. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women.
McMullan CJ; Curhan GC; Schernhammer ES; Forman JP
Am J Epidemiol; 2013 Jul; 178(2):231-8. PubMed ID: 23813704
[TBL] [Abstract][Full Text] [Related]
5. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
7. First-morning urinary melatonin and breast cancer risk in the Guernsey Study.
Wang XS; Tipper S; Appleby PN; Allen NE; Key TJ; Travis RC
Am J Epidemiol; 2014 Mar; 179(5):584-93. PubMed ID: 24418683
[TBL] [Abstract][Full Text] [Related]
8. Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies.
Li Y; Huang T; Redline S; Willett WC; Manson JE; Schernhammer ES; Hu FB
Lancet Diabetes Endocrinol; 2024 Jun; 12(6):404-413. PubMed ID: 38710189
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the association between melatonin secretion and diabetes in elderly: The HEIJO-KYO cohort.
Obayashi K; Yamagami Y; Iwamoto J; Kurumatani N; Saeki K
Clin Endocrinol (Oxf); 2018 Dec; 89(6):750-756. PubMed ID: 30151926
[TBL] [Abstract][Full Text] [Related]
10. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
[TBL] [Abstract][Full Text] [Related]
11. Urinary melatonin and risk of ovarian cancer.
Poole EM; Schernhammer E; Mills L; Hankinson SE; Tworoger SS
Cancer Causes Control; 2015 Oct; 26(10):1501-6. PubMed ID: 26223889
[TBL] [Abstract][Full Text] [Related]
12. Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.
Obayashi K; Saeki K; Kurumatani N
J Urol; 2014 Jun; 191(6):1816-21. PubMed ID: 24384156
[TBL] [Abstract][Full Text] [Related]
13. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
[TBL] [Abstract][Full Text] [Related]
14. Association between urinary 6-sulfatoxymelatonin excretion and arterial stiffness in the general elderly population: the HEIJO-KYO cohort.
Obayashi K; Saeki K; Kurumatani N
J Clin Endocrinol Metab; 2014 Sep; 99(9):3233-9. PubMed ID: 24878050
[TBL] [Abstract][Full Text] [Related]
15. Effects of Cataract Surgery on Melatonin Secretion in Adults 60 Years and Older: A Randomized Clinical Trial.
Nishi T; Saeki K; Miyata K; Yoshikawa T; Ueda T; Kurumatani N; Obayashi K; Ogata N
JAMA Ophthalmol; 2020 Apr; 138(4):405-411. PubMed ID: 32134436
[TBL] [Abstract][Full Text] [Related]
16. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
17. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
[TBL] [Abstract][Full Text] [Related]
18. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
[TBL] [Abstract][Full Text] [Related]
19. Positive effect of daylight exposure on nocturnal urinary melatonin excretion in the elderly: a cross-sectional analysis of the HEIJO-KYO study.
Obayashi K; Saeki K; Iwamoto J; Okamoto N; Tomioka K; Nezu S; Ikada Y; Kurumatani N
J Clin Endocrinol Metab; 2012 Nov; 97(11):4166-73. PubMed ID: 22948764
[TBL] [Abstract][Full Text] [Related]
20. Associations between urinary 6-sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes.
Tanaka K; Okada Y; Maiko H; Mori H; Tanaka Y
J Diabetes Investig; 2021 Apr; 12(4):601-609. PubMed ID: 33460308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
